SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: Implications for blood safety, diagnostics, treatment, and molecular epidemiology
2 references·2 citing·14 second hop
Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: Implications for blood safety, diagnostics, treatment, and molecular epidemiology (2006)Surveillance of the genetic variation in …Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Human immunodeficiency virus,…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…Blood supply safety: an NHLBI perspective (2008)Blood supply safety: an NHLBI…Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors (2006)Lessons and opportunities fro…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)The Risk of Transfusion-Transmitted Viral Infections (1996)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood Donation (1998)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Research partnerships between blood services and public health authorities: An international, cross‐sectional survey (2022)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)International application of the Incidence Rate/Window Period model (2002)Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001 (2003)Developing an administrative plan for transfusion medicine—a global perspective (2005)Sexual risk behaviour and donor deferral in Europe (2014)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)
this work references cited by second hop

References

  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2005Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing95 cited

Cited by

  • 2008Blood supply safety: an NHLBI perspective12 cited
  • 2006Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors10 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work